DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ampicillin and Sulbactam (Ampicillin Sodium / Sulbactam Sodium) - Published Studies


Published Studies Related to Ampicillin and Sulbactam (Ampicillin / Sulbactam)

Well-designed clinical trials related to Ampicillin and Sulbactam (Ampicillin / Sulbactam)

A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam). [2011.04.18]

Ampicillin/sulbactam versus cefuroxime as antimicrobial prophylaxis for cesarean delivery: a randomized study. [2010.11.30]

Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients. [2009.04]

High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii. [2007]

The value of chemoprophylaxis against Enterococcus species in elective cholecystectomy: a randomized study of cefuroxime vs ampicillin-sulbactam. [2006.12]

Cefepime vs. Ampicillin/Sulbactam and Aztreonam as antibiotic prophylaxis in neurosurgical patients with external ventricular drain: result of a prospective randomized controlled clinical trial. [2006.06]

[Efficacy and safety of Sultamicillin (Ampicillin/Sulbactan) and Amoxicillin/Clavulanic acid in the treatment of upper respiratory tract infections in adults--an open-label, multicentric, randomized trial] [2006.01]

Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia. [2006]

Peritonsillar abscess: a comparison of outpatient i.m. clindamycin and inpatient i.v. ampicillin/sulbactam following needle aspiration. [2005.06]

Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to neonatal calves. [2005.05]

An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. [2005.03]

Well-designed clinical trials possibly related to Ampicillin and Sulbactam (Ampicillin / Sulbactam)

Efficacy of prophylactic antibiotic administration for breast cancer surgery in overweight or obese patients: a randomized controlled trial. [2013]

Antibiotics for meconium-stained amniotic fluid in labour for preventing maternal and neonatal infections. [2010.12.08]

Pharmacodynamic assessment of Amoxicillin-Sulbactam against Acinetobacter baumannii: searching the optimal dose and infusion time through a human ex-vivo model. [2009.10]

Intravenous amoxicillin-sulbactam against Escherichia coli: optimizing the dose, component ratio and infusion time using a human pharmacodynamic model. [2009.06]

Comparative evaluation of efficacy and safety of cefotaxime-sulbactam with amoxicillin-clavulanic acid in children with lower respiratory tract infections. [2008.11]

Randomized, multicentre, comparative clinical evaluation of cefuroxime-sulbactam versus amoxicillin-clavulanic acid therapy in the treatment of lower respiratory tract infections. [2008.11]

Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim infection in stroke study (MISS). [2008.04]

Clindamycin versus Unasyn in the treatment of facial cellulitis of odontogenic origin in children. [2007.03]

Comparison of the pharmacokinetics of piperacillin and sulbactam during intermittent and continuous intravenous infusion. [2007]

Randomized prospective study on prophylactic antibiotics in clean orthopedic surgery in one ward for 1 year. [2006.01]

Pharmaceutical cost comparison analysis of antimicrobial use for surgical prophylaxis on gastrectomy patients in a tertiary care hospital. [2005.10]

Variceal bleeding in portal hypertension: bacterial infection and comparison of efficacy of intravenous and per-oral application of antibiotics--a randomized trial. [2005.10]

Amoxicillin-sulbactam versus amoxicillin-clavulanic acid for the treatment of non-recurrent-acute otitis media in Argentinean children. [2005.09]

Piperacillin-sulbactam versus piperacillin-tazobactam: a multicentre, randomised, single-blind, controlled clinical trial. [2005.07]

Treatment of childhood complicated community-acquired pneumonia with amoxicillin/sulbactam. [2005.06]

Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients. [2005.04]

Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study. [2005.04]

Effect of amoxicillin sulbactam in threatened preterm labour with intact membranes: a randomised controlled trial. [2005.03.01]

Other research related to Ampicillin and Sulbactam (Ampicillin / Sulbactam)

Effects of ampicillin/sulbactam and enrofloxacin on the blood pressure of isoflurane anesthetized dogs. [2013]

T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam. [2013]

A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam). [2011]

Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population. [2010.10]

Ampicillin/sulbactam versus cefuroxime as antimicrobial prophylaxis for cesarean delivery: a randomized study. [2010]

Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections. [2009.09]

Risk of underdosing of ampicillin/sulbactam in patients with acute kidney injury undergoing extended daily dialysis--a single case. [2009.07]

A clinical comparative study of piperacillin and sulbactam/ampicillin in patients with community-acquired bacterial pneumonia. [2009]

Rational antibiotic therapy and the position of ampicillin/sulbactam. [2008.07]

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia. [2008.06]

Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp. [2008.06]

A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes. [2008.05]

Preseptal and orbital cellulitis: 15-year experience with sulbactam ampicillin treatment. [2008.05]

An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia. [2008.04]

[Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam] [2008.04]

Moxifloxacin vs Ampicillin/Sulbactam in Aspiration Pneumonia and Primary Lung Abscess. [2008.02]

Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia. [2007.10]

Ampicillin/sulbactam: current status in severe bacterial infections. [2007]

Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial. [2006.08.14]

[Ampicillin and sulbactam concentrations in the irradiated mandible after oral squamous cell cancer] [2005.07]

Other possibly related research studies

Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data. [2006]

Decision-making analysis for selection of antibiotic treatment in intra-abdominal infection using preference measurements. [2006.10]

[Bacteria isolated from pleural fluid and their resistance to antimicrobials] [2006.04]

[Case of anaphylactic shock induced by an antibiotic after induction of anesthesia] [2006.10]

Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials. [2006.10]

Retropharyngeal abscess in children: the emerging role of group A beta hemolytic streptococcus. [2006.09]

Soft tissue infections in children: a retrospective analysis of 242 hospitalized patients. [2006.08]

[Microorganisms isolated from middle ear cultures and their antibacterial susceptibility in patients with chronic suppurative otitis media] [2006]

Acute iliopsoas and adductor brevis abscesses presenting with proximal leg muscle weakness. [2006.06]

Effect of a selective decontamination of the digestive tract regimen including parenteral cefepime on establishment of intestinal colonization with vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in mice. [2006.07]

The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release. [2006.07]

Isolated hepatic tuberculous abscess in a renal transplant recipient. [2006.06]

Review of pharmacokinetic, pharmacodynamic and clinical studies with a modern combination of amoxicillin/sulbactam. [2006]

[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa] [2006.02]

Systematic review of antimicrobial treatments for diabetic foot ulcers. [2006.04]

Actinomycotic inflammatory disease and misdiagnosis of ovarian cancer. A case report. [2006.03]

Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus. [2006.04]

A practical application of practice-based learning: development of an algorithm for empiric antibiotic coverage in ventilator-associated pneumonia. [2006.04]

A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers. [2006.04]

Hospital-based strategies for combating resistance. [2006.04.15]

[Diagnosis and therapy of aspiration pneumonia] [2006.03.24]

Ceftriaxone-related hemolysis and acute renal failure. [2006.05]

Potentially multidrug-resistant non-fermentative Gram-negative pathogens causing nosocomial pneumonia. [2006.03]

Does initial choice of antimicrobial therapy affect length of stay for patients with complicated intra-abdominal infections? [2005.10]

Spontaneous bilateral bacterial empyema in a patient with nephrotic syndrome. [2006.09]

[Two leptospirosis cases and review of the national literature] [2005.07]

Ceftriaxone prophylaxis in abdominal, cardiovascular, thoracic, orthopaedic, neurosurgical and general surgery: a review of practice 1996 - 2003. [2005.09]

[Diagnosis of septic arthritis and initial antibiotic treatment] [2005]

Treatment of multidrug resistant Acinetobacter. [2005.12]

Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy. [2005.10.15]

Antimicrobial activity of antibiotics in combination with natural flavonoids against clinical extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae. [2005.07]

Septic arthritis secondary to fusobacterium necrophorum in a 4-year-old girl: case report and review of the literature. [2005.09]

Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period. [2005]

A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin. [2005.07]

Spondylodiscitis after lumbar microdiscectomy: effectiveness of two protocols of intraoperative antibiotic prophylaxis in 1167 cases. [2005.10]

Antimicrobial treatment of lower respiratory tract infections in the hospital setting. [2005.07]

Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates. [2005.06]

[Critical odontogenic infection involving the mediastinum. Case report] [2005.07]

[Pharmacoeconomic profile of antibiotics used in the treatment of lower respiratory tract infections in geriatric patients] [2005.03]

Staphylococcal skin infections in children: rational drug therapy recommendations. [2005]

[Changes in the antimicrobial susceptibility of Escherichia coli isolates from nosocomial versus community-acquired urinary tract infections] [2005.04]

Response of visual loss in allergic fungal sinusitis to oral corticosteroids. [2005.03]

[Combination therapy of micafungin and itraconazole for a case of pulmonary aspergillosis] [2005.02]

Lemierre syndrome. [2005.04]

Pneumonia in patients who require prolonged mechanical ventilation. [2005.02]

Enterococcal meningitis caused by Enterococcus casseliflavus. First case report. [2005.01.14]

Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy. [2005.01]

Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey. [2005.01]

Pulmonary abscess due to leflunomide use in rheumatoid arthritis: a case report. [2005.03]

Acute bilateral diffuse corneal opacity in a child. [2007.04]

Bilateral eyelid edema and orbital cellulitis associated with Pott's puffy tumor. [2007.03]

Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome. [2007.02]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017